Literature DB >> 30630872

Microvessel density in breast cancer: the impact of field area on prognostic informativeness.

Maria Ryssdal Kraby1, Signe Opdahl2, Hege Giercksky Russnes3,4, Anna M Bofin5.   

Abstract

AIMS: Tumour microvessel density (MVD) is assessed by counting vessels in the most vascularised tumour region, the vascular hot spot. Current uncertainty regarding the prognostic role of MVD in breast cancer could, in part, be explained by variations in field area size for MVD assessment. We aimed to identify the field area size that provides the most accurate prognostic information in breast carcinoma.
METHODS: MVD was assessed in 212 tumours. von Willebrand factor positively stained vessels were counted in 10 consecutive visual fields in vascular hotspots. The 10 visual fields in the original counting sequence (MVD-Consecutive) were sorted from highest to lowest vessel count (MVD-Decreasing), and randomly (MVD-Random). After adding counts from one visual field at a time, mean MVD was calculated for each cumulative field area. The prognostic informativeness of each field area and sorting strategy were compared.
RESULTS: Median MVD decreased with increasing field size for MVD-Decreasing and MVD-Consecutive. A 0.35 mm2 total field area comprising only the highest vessel counts provided the most accurate prognostic information (MVD-Decreasing, HR for breast cancer death 1.06 per 10 vessels/mm2 increase, 95% CI 1.03 to 1.10). MVD-Decreasing gave more accurate prognostic information than MVD-Consecutive and MVD-Random, with decreasing prognostic informativeness with increasing field area.
CONCLUSIONS: Median MVD and its prognostic informativeness decreased with increasing field area. Assessing MVD in a carefully selected small field area of 0.35 mm2 provides the most accurate prognostic information. This could facilitate the implementation of MVD assessment in breast cancer. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  blood vessels; breast cancer; breast pathology; immunohistochemistry; tumour biology

Mesh:

Substances:

Year:  2019        PMID: 30630872     DOI: 10.1136/jclinpath-2018-205536

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

1.  Biological correlates of tumor perfusion and its heterogeneity in newly diagnosed breast cancer using dynamic first-pass 18F-FDG PET/CT.

Authors:  Neree Payan; Benoit Presles; François Brunotte; Charles Coutant; Isabelle Desmoulins; Jean-Marc Vrigneaud; Alexandre Cochet
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-08       Impact factor: 9.236

2.  Exosomal LBH inhibits epithelial-mesenchymal transition and angiogenesis in nasopharyngeal carcinoma via downregulating VEGFA signaling.

Authors:  Anbiao Wu; Ning Luo; Yuling Xu; Nan Du; Li Li; Qicai Liu
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

3.  Effects of acute exercise training on tumor outcomes in men with localized prostate cancer: A randomized controlled trial.

Authors:  Sissal Sigmundsdóttir Djurhuus; Tim Schauer; Casper Simonsen; Birgitte Grønkaer Toft; Adina Ruth Deborah Jensen; Janine Terra Erler; Martin Andreas Røder; Pernille Hojman; Klaus Brasso; Jesper Frank Christensen
Journal:  Physiol Rep       Date:  2022-10

4.  Multicenter phase II study of apatinib single or combination therapy in HER2-negative breast cancer involving chest wall metastasis.

Authors:  Huiping Li; Cuizhi Geng; Hongmei Zhao; Hanfang Jiang; Guohong Song; Jiayang Zhang; Yaxin Liu; Xinyu Gui; Jing Wang; Kun Li; Zhongsheng Tong; Fangyuan Zhao; Junlan Yang; Guoliang Chen; Qianyu Liu; Xu Liang
Journal:  Chin J Cancer Res       Date:  2021-04-30       Impact factor: 5.087

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.